Featured Genomics Experts

Emanuele Andreano is an immunologist and biotech innovator redefining how vaccines are discovered for pandemic threats. As Head of Serology and Immunology at the Fondazione Biotecnopolo di Siena and a leader in the European Vaccine Hub, he works at the intersection of AI, immunology, and global health. He pioneered Reverse Vaccinology 3.0, a breakthrough approach that can identify entirely new vaccine targets in days instead of years. In a first-of-its-kind demonstration, his team showed that artificial intelligence can predict unknown viral antigens directly from human antibody sequences—effectively reversing the traditional vaccine discovery process. His work spans monoclonal antibody discovery and next-generation vaccines against emerging pathogens, including mpox and SARS-CoV-2, with direct implications for global pandemic preparedness and biosecurity. Andreano has received international recognition, including the Antonio Feltrinelli Prize from the Accademia Nazionale dei Lincei, awarded in the presence of the President of the Italian Republic Sergio Mattarella, the IUIS Rising Star in Immunology, and a European Research Council (ERC) grant. He also co-directs a vaccinology program at the Institut Pasteur in Paris. “We are entering an era where vaccines can be discovered at unprecedented speed—transforming our ability to fight pandemics and save countless lives.”

Nationally recognized author, speaker and innovation strategist, Corey ignites human potential to connect, evolve and inspire. Known for her broad systems acumen, why-didn't-i-think-of-that ideas, and for crashing servers (more than once!) with a contact list the size of the Atlantic, Corey leads a global clientele to discover novel pathways to new or renewed efficiency, function and flow. Corey’s articles, ideas and savvy solutions have been featured in hundreds of media outlets, on television, radio, online, and in-print such as Good Morning America, Real Simple, LA Times, NPR, CNN and more. Corey possesses a unique knack for bridging people, ideas, concepts and solutions. Corey's collaborators have included nationally known entities in media, food, home, health/wellness, beauty and fashion, including Dr. Oz’s HealthCorps, HGTV, Non-GMO Project, Goodwill Industries International, Association of Zoos and Aquariums, Whole Foods Market, Green Schools Alliance, Green America, Honest Tea, Larabar, Nature’s Path, and Plum Organics. Resourceful, obsessively relationship focused and a born idea maven, Corey’s orientation towards leadership and meaningful collaboration is homegrown from a lineage of visionary pioneers. Corey is analytical, organized, creative, and efficiency-reverent (poster-child ENTJ) and is known for high-level communications, as well as her ability to envision, comprehend, communicate and integrate a spectrum of views, from bird’s eye to the minutia, and strategies, be they long-term or on-the-spot. Solving problems by merging game-changing strategy with carefully curated partnerships is simply in her blood. Corey brings and embraces a diverse perspective through her expertise in health, sustainability, marketing, public relations, branding, entertainment, clinical psychology and systems-oriented evolution.

Dr. James Utley is a pioneering scientist at the forefront of cellular therapy, AI, and data science. A Johns Hopkins-educated Immunohematology expert and Certified Advanced Biotherapies Professional (CABP), he also holds advanced certifications in data science and machine learning. While serving as Technical Director at a major healthcare organization, Dr. Utley oversaw more than 150,000 successful cellular transfusions and spearheaded advancements that significantly improved patient outcomes. This experience included leading initiatives for the Department of Defense, where he revolutionized cellular transfusion practices. His innovative approach is further exemplified by his FDA-approved work and numerous publications in leading scientific journals. Dr. Utley is also known for his bold, hands-on approach to research, embodying the spirit of a "biohacker" by pushing the boundaries of CRISPR and genetic engineering through self-experimentation. This unique blend of rigorous scientific training and unconventional methods has earned him the moniker "the pirate" within the biohacker community.

Tomo Marjanovic is the Founder and CEO of Aspire Rejuvenation Clinic, a multi-million dollar hormone optimization and regenerative medicine company with clinics in four U.S. cities and expansion underway in Cleveland and Dubai. Named a Top 100 Healthcare Visionary by IFAH, Marjanovic has treated thousands of patients through bioidentical HRT, peptide therapy, stem cell and exosome treatments, and medical weight loss programs. Before building Aspire, Marjanovic spent 12 years in law enforcement in Ohio and Florida, earning the Public Safety Medal of Valor. After chronic night shift work destroyed his hormonal health and the medical system failed to help, he got certified in Advanced Bioidentical Hormone Replacement Therapy through Worldlink Medical and built the company he wished existed when he was the patient. Marjanovic is the author of "Operation Optimal: Health, Wellness, & Becoming Your Best You" and host of the Tomo Talks podcast. He holds a BA in Criminal Justice Administration (Cum Laude) from Tiffin University and is a former competitive bodybuilder. His work has been featured in USA Today, NY Post, Miami Herald, Modern Luxury, and Authority Magazine. He is available to speak on hormone optimization, testosterone therapy, longevity medicine, regenerative therapies, peptides, men's health, stress and cortisol, health entrepreneurship, veteran and first responder wellness, the GLP-1 market, healthcare franchising, and the intersection of health and wealth.

Founder & CEO of Genbounty - AI safety & compliance testing. Genbounty is a an AI safety testing hub and provider of EU AI Act compliance and certification. About me AppSec SME, AI Engineer, Developer | BSc, MBA, PRINCE2, CompTIA+, CISSP

With a PhD in molecular genetics and as a specialist in data science, Céline Chantry-Darmon has over twenty years of experience in biomedical research and complex data analysis. As Scientific Director at Tekkare, she works on developing trustworthy artificial intelligence for healthcare. She is also committed to promoting inclusive and responsible artificial intelligence, and to advancing women in science and technology.

Clinical trial management of two stem cell clinical trials. I have a passion for data science analytics and rigorous pattern-seeking. I believe in leading from the front and making sure the team is well taken care of. *Managing 2 stem cell clinical trials, NCT02838316 and NCT05421689*30 peer-reviewed publications.*>12,000 citations.*2 provisional patents.*Co-founded startup.*Co-developed departmental leadership program.*Strong track record of grant funding and collaboration building.* Associated Editor for two flagship scientific journals (Stem Cells, Journal of Extracellular Biology).GOOGLE SCHOLAR PROFILEhttps://scholar.google.com/citations?user=3uQtjEEAAAAJ&hl=en

Ryan Farmer is the founder of My Peptide Match, a consumer education site that helps people make sense of GLP-1 medications and the fast-changing peptide landscape. He focuses on simplifying complex topics—like real-world pricing, treatment pathways, sourcing differences, and what questions to ask—so readers can make more informed decisions with their clinician. Ryan tracks emerging trends across weight-loss peptides, compounding and telehealth access, and the economics that shape what consumers actually pay. He’s available to comment on GLP-1 and peptide cost comparisons, patient decision-making, and the broader market shifts driving demand. He also publishes practical reference tools, including a peptide calculator and dosage guide, to support clearer conversations between consumers and providers.

Founder of PeptideLeads, a patient generation agency built specifically for peptide therapy clinics. We deliver qualified patients at $50 each with no retainer and no ad spend from the clinic. Built on a proprietary database of every peptide clinic in the US.

Shane Hellmrich holds a BSc in Health Promotion and has spent the past 11 years independently testing and reviewing online modafinil vendors — placing personal test orders, verifying product authenticity, and documenting shipping reliability across dozens of suppliers. His work at BuyModa.net tracks over 1,300 verified customer transactions and maintains a public testing methodology that has become a trusted reference point for consumers navigating the grey-market pharmaceutical space. Shane's research covers vendor reliability scoring, product authentication, shipping logistics across international jurisdictions, and the pharmacokinetic profiles of generic modafinil products. He is regularly consulted on topics including nootropics and cognitive enhancement, online pharmacy safety and regulation, pharmaceutical sourcing and supply chain transparency, consumer protection in unregulated markets, and the real-world usage patterns of prescription cognitive enhancers. Shane is available for expert commentary, background briefings, and on-the-record quotes for journalists covering health, productivity, pharmacology, biohacking, and consumer safety.

Hey network! I'm Anurag Srivastav Thammera, a graduate of KL University with a deep-rooted passion for entrepreneurship and emerging technology. I have always been driven by the belief that AI can fundamentally transform the way humans live and work — and that belief has shaped every step of my journey, pushing me far beyond the classroom toward building real solutions at the intersection of intelligence and impact. I am the Founder & CTO of KrAIonyX, an AI startup focused on developing large language models, agentic systems, and intelligent products that act as capable human assistants. At KrAIonyX, I lead the vision of deploying high-assurance AI across high-potential sectors — particularly EdTech and HealthTech — where agentic AI can meaningfully improve outcomes for people. I bring hands-on experience building real-world AI products, including KrAiGita, a flagship product from the KrAIonyX ecosystem. My work sits at the frontier of where cutting-edge AI research meets practical, human-centered impact. If you're someone who builds with purpose, thinks beyond the ordinary, and wants to shape the future with ideas rather than just effort — let's connect. Always open to conversations with like-minded founders, builders, and visionaries who believe the best is still yet to be created.

I am a Bioinformatician with extensive experience of analyzing Genomics and Transcriptomics data from Next Generation Sequencing Platforms. I enjoy designing, implementing and automating computational pipelines for Biological Data Analysis using multiple programming languages. I also possess over three years of experience working in wet lab with several Molecular Biology tools. I have worked as teaching assistant for both undergrads and grad students.I enjoy solving problems independently as well as by being part of a collaborative inter-disciplinary team.

Len May is a Certified Medical Cannabis Specialist with 25 years of cannabis- related experience. He was president of the Cannabis Action Network, and a lifetime board member of the California Cannabis Association as well as the Association of Cannabis Specialists. May has a Masters of Medical Cannabis and an Endocannabinoid Formulation Specialist Certification from the Institute for the Advancement of Integrative Medicine. Currently, Len May is CEO and Co-Founder of Endocanna Health, a Bio-Science Technology company and the parent company of Endo DNA. Mr. May is an accomplished public speaker having presented on these topics on some of the world’s most prestigious stages in his mission to help educate the population about the healing powers personalized of cannabis.

Dr. Giovanni Abbadessa is a seasoned oncology developer with over 20 years of experience in advancing innovative therapies across biotech, pharmaceutical, and nonprofit sectors. He joined ModeX Therapeutics as Chief Medical Officer, where he leads the development of the company’s multispecific biologics for cancer and infectious diseases. Prior to ModeX, Dr. Abbadessa was Vice President and Head of Oncology Early Development at Sanofi, where he spearheaded the clinical development of 16 experimental oncology drugs, guiding them from first-in-human studies through to Phase 2 trials. He established a dynamic team of 25 professionals and played a pivotal role in in-licensing 10 clinical assets. Dr. Abbadessa contributed to strategic oversight across multiple portfolios, including Phase 3 assets and partnerships, and collaborated with Investor Relations on oncology-focused initiatives.

I'm Neil, the CEO of Phyla. Our patented phage technology kills acne without harming your skin microbiome...no side effects. Phages are the most abundant micro-organism on the planet, and they keep the planet healthy by killing harmful bacteria. Phages are also found on healthy skin. Phyla's serum gets to the root cause of acne, the c.acnes bacteria, clearing your hormonal, cystic and teenage acne.We hear from so many customers who've tried Accutane, Antibiotics and Benzoyl Peroxide to no success until they used Phyla. Acne sucks and it's heartwarming to hear their success stories.I was previously the COO at GenoPalate, a nutrigenomics start-up that personalized nutrition based on DNA analysis. I spent a decade at Colgate-Palmolive, building brands and driving growth across Latin America, Asia and the US. I have an MBA from Kellogg and a BS in Finance from Boston College.

At Crystal Ball, we've developed an innovative solution to address the challenge of…